Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 3, 1996, Pages 717-725

  Yu, Yan ^a,b   Waterman, Frank M ^a   Suntharalingam, Nagalingam ^a   Schulsinger, Alan ^a,c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

125iodine; Brachytherapy; Prostate

Indexed keywords

IODINE 125;

ARTICLE; CANCER RADIOTHERAPY; COMPUTER MODEL; IMPLANTATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIOISOTOPE THERAPY;

BRACHYTHERAPY; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 0030057732     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02153-1     Document Type: Article

References (12)

1. 125I seeds. Med. Phys. 3:48-51; 1976.
2. Anderson, L. L.; Moni, J. V.; Harrison, L. B. A nomograph for permanent implants of palladium-103 seeds. Int. J. Radiat. Oncol. Biol. Phys. 27:129-135; 1993.
3. Anderson, L. L.; Nath, R.; Olch, A. J.; Roy, J. N. American Endocurietherapy Society recommendations for dose specification in brachytherapy. Endocuriether. Hyperther. Oncol. 7:1-12; 1991.
4. Blasko, J. C.; Radge, H.; Schumacher, D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocuriether. Hyperther. Oncol. 3:131-139; 1987.
5. Dutreix, A.; Chassagne, D.; Ash, D.; Hanson, W. F.; Visser, A. G.; Wilson, J. F.; Wambersie, A. A report on ICRU recommendations on dose and volume specification for reporting interstitial therapy. IAEA-SM-330-63; 1993.
6. Holm, H. H.; Juul, N.; Pedersen, J. F.; Hansen, H.; Stroyer, I. Transperineal iodine-125 seed implantation in prostatic cancer guided by transrectal ultrasonography. J. Urol. 130:283-286; 1983.
7. 125I seeds. Int. J. Radiat. Oncol. Biol. Phys. 28:971-978; 1994.
8. Nath, R.; Anderson, L. L.; Ixton, G.; Weaver, K. A.; Williamson, J. F.; Meigooni, A. S. Dosimetry of Interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med. Phys. 22:209-234; 1995.
9. Roy, J. N.; Wallner, K. E.; Chiu-Tsao, S.; Anderson, L. L.; Ling, C. C. CT-based optimized planning for transperineal prostate implant with customized template. Int. J. Radiat. Oncol. Biol. Phys. 21:483-489; 1991.
10. Roy, J. N.; Wallner, K. E.; Harrington, P. J.; Ling, C. C.; Anderson, L. L. A CT-based evaluation method for permanent implants: Application to prostate. Int. J. Radiat. Oncol. Biol. Phys. 26:163-169; 1993.
11. Saw, C. B.; Suntharalingam, N. Quantitative assessment of interstitial implants. Int. J. Radiat. Oncol. Biol. Phys. 20:135-139; 1991.
12. 125I boost therapy. Med. Phys. 10:155-158; 1983.